Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR
- PMID: 19561084
- PMCID: PMC2755659
- DOI: 10.1074/jbc.M109.027748
Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR
Abstract
In normal physiological states mTOR phosphorylates and activates Akt. However, under diabetic-mimicking conditions mTOR inhibits phosphatidylinositol (PI) 3-kinase/Akt signaling by phosphorylating insulin receptor substrate-1 (IRS-1) at Ser-636/639. The molecular basis for the differential effect of mTOR signaling on Akt is poorly understood. Here, it has been shown that knockdown of mTOR, Raptor, and mLST8, but not Rictor and mSin1, suppresses insulin-stimulated phosphorylation of IRS-1 at Ser-636/639 and stabilizes IRS-1 after long term insulin stimulation. This phosphorylation depends on the PI 3-kinase/PDK1 axis but is Akt-independent. At the molecular level, Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of IRS-1 and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR. IRS-1 lacking the SAIN domain does not interact with Raptor, is not phosphorylated at Ser-636/639, and favorably interacts with PI 3-kinase. Overall, these data provide new insights in the molecular mechanisms by which mTORC1 inhibits PI 3-kinase/Akt signaling at the level of IRS-1 and suggest that mTOR signaling toward Akt is scaffold-dependent.
Figures
Similar articles
-
The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.Nutrients. 2017 Oct 27;9(11):1176. doi: 10.3390/nu9111176. Nutrients. 2017. PMID: 29077002 Free PMC article. Review.
-
Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.Mol Endocrinol. 2010 Apr;24(4):766-78. doi: 10.1210/me.2009-0328. Epub 2010 Mar 4. Mol Endocrinol. 2010. PMID: 20203102 Free PMC article.
-
Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.J Biol Chem. 2010 Jan 1;285(1):80-94. doi: 10.1074/jbc.M109.029637. Epub 2009 Oct 28. J Biol Chem. 2010. PMID: 19864431 Free PMC article.
-
Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction.J Cell Biochem. 2010 Apr 15;109(6):1172-84. doi: 10.1002/jcb.22496. J Cell Biochem. 2010. PMID: 20127721 Free PMC article.
-
Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2).Biochem Soc Trans. 2013 Aug;41(4):896-901. doi: 10.1042/BST20130018. Biochem Soc Trans. 2013. PMID: 23863152 Free PMC article. Review.
Cited by
-
Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma.Int J Clin Exp Pathol. 2010 Nov 20;4(1):13-21. Int J Clin Exp Pathol. 2010. PMID: 21228924 Free PMC article.
-
Akt phosphorylates insulin receptor substrate to limit PI3K-mediated PIP3 synthesis.Elife. 2021 Jul 13;10:e66942. doi: 10.7554/eLife.66942. Elife. 2021. PMID: 34253290 Free PMC article.
-
The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.Nutrients. 2017 Oct 27;9(11):1176. doi: 10.3390/nu9111176. Nutrients. 2017. PMID: 29077002 Free PMC article. Review.
-
Disruption of mTORC1 rescues neuronal overgrowth and synapse function dysregulated by Pten loss.Cell Rep. 2022 Nov 1;41(5):111574. doi: 10.1016/j.celrep.2022.111574. Cell Rep. 2022. PMID: 36323257 Free PMC article.
-
miR-155-5p upregulation ameliorates myocardial insulin resistance via mTOR signaling in chronic alcohol drinking rats.PeerJ. 2021 Apr 5;9:e10920. doi: 10.7717/peerj.10920. eCollection 2021. PeerJ. 2021. PMID: 33868799 Free PMC article.
References
-
- Sarbassov D. D., Ali S. M., Sabatini D. M. (2005) Curr. Opin. Cell Biol. 17,596–603 - PubMed
-
- Kim D. H., Sarbassov D. D., Ali S. M., King J. E., Latek R. R., Erdjument-Bromage H., Tempst P., Sabatini D. M. (2002) Cell 110,163–175 - PubMed
-
- Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J., Yonezawa K. (2002) Cell 110,177–189 - PubMed
-
- Sarbassov D. D., Guertin D. A., Ali S. M., Sabatini D. M. (2005) Science 307,1098–1101 - PubMed
-
- Guertin D. A., Stevens D. M., Thoreen C. C., Burds A. A., Kalaany N. Y., Moffat J., Brown M., Fitzgerald K. J., Sabatini D. M. (2006) Dev. Cell 11,859–871 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
